+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

World Top 10 Pediatric Healthcare Market - Opportunities and Forecasts, 2017 - 2023

  • PDF Icon

    Report

  • September 2019
  • Region: Global
  • Allied Market Research
  • ID: 3773189
Pediatric healthcare is dealing with the treatment of child related diseases, their development and care. Children often suffer from respiratory, gastrointestinal and other chronic disease because of lower immunity. The global market for pediatric healthcare is accounted to approximately $83 billion in 2013 and expected to grow at 7.8% CAGR in future. Increase in demand for chronic disease treatment, Diarrhea and injury related disease is more common in children; however, these diseases vary from short term to long-term treatments that consume a lot time and exert financial pressures on the parents. Changes in child care trend increases the prevalence rate of pediatric diseases. This report provides detail information about current scenario of pediatric treatment and expected growth in it.

Eminent market players include Abbott Laboratories, Gilead Sciences, GlaxosmithklinePlc, Johnson & Johnson, Eli Lilly, AxcanPharma USA, Pfizer, Sanofi, and Wyeth.

KEY BENEFITS

In depth analysis of key drivers, restraints and opportunities of pediatric healthcare market with impact analysis
Porters five forces model provide macro level analysis of market factors that are influencing the growth
Key developmental strategies adopted by top market players engaged in this business to provide better understanding of potential opportunities and challenges in this market
Market estimation for treatment, therapeutics, duration of disease and geographic segment is derived from current market scenario and expected market trends
The report provides for in-depth understanding of the market scenarios in various geographic regions so that key players can make plans to explore opportunities in specific regions

KEY MARKET SEGMENTS

GLOBAL MARKET, BY PERIOD OF DISEASES

Long term disease
Short term disease

GLOBAL MARKET, BY THERAPEUTICS

Asthma and allergies
Diabetes,
Obesity,
Cerebral palsy
Chronic illness
Others

GLOBAL MARKET, BY TREATMENTS

Immunotherapy
Dietary Restrictions
Medications
Surgical Procedures
Others

GLOBAL MARKET, BY GEOGRAPHY

North America
Europe
Asia-Pacific
ROW

KEY AUDIENCES

Pharmaceutical companies engaged in manufacturing, development and commercialization of drugs and surgical equipments
Drug dealers and wholesalers
Research institutes and facilities
Educational and Academics institutes

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...